<DOC>
	<DOCNO>NCT01631357</DOCNO>
	<brief_summary>This randomize , open-label phase II/III study evaluate effect chemotherapy combination autologous cytokine-induced killer Cell immunotherapy patient stage IIIb-IV squamous non-small-cell lung cancer</brief_summary>
	<brief_title>Study Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy Treat Lung Cancer</brief_title>
	<detailed_description>1 . Phase II/III study , 2 . Randomized , open-label study , 3. evaluated effect chemotherapy combination autologous cytokine-induced killer Cell immunotherapy compare chemotherapy patient stage IIIb-IV squamous non-small-cell lung cancer</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Sex : male female Age : 18 80 year Histology : squamous nonsmallcell lung cancer Clinical stage : stage IIIb stage IV Therapy : receive chemotherapy , radiotherapy , immunotherapy entry study Karnofsky performance status : 50 % Expected survival : 2 month Laboratory test result 7 day start treatment : White blood cell : 3.0 × 109/L Platelets : 100 × 109/L Neutrophils : 1.5 × 109/L Hemoglobin : 80g/L Serum glutamate pyruvate transaminase : le 2.5 fold upper normal limit ( ULN ) Serum glutamicoxal ( ) acetic transaminase : le 2.5 × ULN Serum bilirubin : le 1.25 × ULN Serum creatinine : le 1.25 × ULN pregnancy test : test woman childbearing period must negative 7 day start treatment Contraception : male female subject childbearing period must adopt reliable method contraception entry study 30 day stop study Informed consent : subject must ability understand voluntarily sign write informed consent History neoplasm : neoplasms Medical history : mental disease , congestive heart failure , severe coronary artery disease , cardiac arrhythmia , concomitant corticosteroid therapy History allergy : allergic study drug Metastasis : clinical symptom brain metastasis Other clinical trial : subject receive clinical trial study Laboratory test : serum test human immunodeficiency virus , hepatitis B virus , hepatitis C virus positive Woman : pregnant lactate woman Compliance : poor compliance History neoplasm : neoplasm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>